2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Anders Kvanta: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bevacizumab for Central Retinal Vein Occlusion Study bevacizumab, Sham bevacizumab injection - Central Retinal Vein Occlusion | Phase 3 | Completed | Anders Kvanta | 60 | 2009-05-01 | 2011-11-22 |
| The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study ranibizumab, TTT, Sham TTT - Neovascular Age-related Macular Degeneration | Phase 3 | Completed | Anders Kvanta | 100 | 2008-02-01 | 2011-11-22 |
Macular Degeneration (1) · Macular Edema (1) · Retinal Vein Occlusion (1)
Bevacizumab (1) · Ranibizumab (1)
Sweden (2)